Skip to main content
. 2022 Sep 23;13:1025872. doi: 10.3389/fimmu.2022.1025872

Figure 1.

Figure 1

Mechanism of anti-tumor humoral immunity after SBRT. After SBRT, many tumor-associated antigen (TAA) fragments are released into the blood and stimulate the differentiation of B lymphocytes into plasma cells. Furthermore, plasma cells produce antibodies and bind to tumor cells to form antigen–antibody complexes, and are then phagocytosed and cleared by macrophages.